| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.9 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |